ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

ABO Antibody Removal of Plasmapheresis (PP) with Intravenous Immunoglobulin (IVIG) before ABO-Incompatible (ABOI) Kidney Transplantation

D. Lee, B. Kim, J. Kim

Medicine, Maryknoll General Hospital, Busan, Republic of Korea
Laboratory Medicine, Maryknoll General Hospital, Busan, Republic of Korea
Surgeon, Maryknoll General Hospital, Busan, Republic of Korea

Meeting: 2013 American Transplant Congress

Abstract number: D1758

Background: ABOI kidney transplantation is an inevitable option to overcome organ shortage. Outcome of ABOI grafts improved and became equivalent to compatible grafts. There were few data on success rates of ABO antibody removal or relating to patients in who antibody removal fails. The purpose of this study was to evaluate the likelihood of achieving transplantation depending on ABO antibody titers.

Methods: 55 patients were enrolled between 2007-2012. We perform ABOI kidney transplantation using anti-CD20 antibody, tacrolimus and PP with IVIG. The median antibody titer was 1:64 (Range 8-4096). Transplantation was proceeded when the ABO titer reached ≤ 1:8. To determine the likelihood of achieving transplantation, the number of PP required to proceed transplantation and baseline ABO titer were analyzed.

Results: All 55 patients(100%) successfully completed transplantation after 5.75±4.3 PP with IVIG. Three patients did not reach target ABO titer and their achieved ABO titers at the time of transplantation were 1:16. (initial ABO titer were 1:256 in one patient, 1:2048 in one patient, and 1:1024 in one patient)

The median follow-up duration was 18.1 month (Range 0.9-71.8). The median ABO titer was 2 (Range 1-16) at the time of transplantation, 4(Range 1-64) at 1month posttransplantation and 4 (Range 4-128) at the last follow-up, respectively. The number of PP to reach an ABO titer of ≤ 1:8 was significantly correlated with baseline ABO IgG titers (r2=0.829, P < 0.001).

Conclusions: All 55 patients successfully preformed ABOI kidney transplantation without failure to achieve transplantation. Three patients even failed to reach target titer at the time of transplantation, however, all of them were successfully transplanted. Optimal ABO titer at the time of transplantation remains debatable, therefore we might carefully need to tailor our protocol with increasing cut-off ABO titer of 1:16. ABOI transplantation would be an accepted method of expanding kidney donor pool.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Lee D, Kim B, Kim J. ABO Antibody Removal of Plasmapheresis (PP) with Intravenous Immunoglobulin (IVIG) before ABO-Incompatible (ABOI) Kidney Transplantation [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/abo-antibody-removal-of-plasmapheresis-pp-with-intravenous-immunoglobulin-ivig-before-abo-incompatible-aboi-kidney-transplantation/. Accessed May 10, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences